Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction

Journal of Clinical Pathology

Volumn 59, Issue 2, 2006, Pages 196-201

  Meuwissen, M ^a   Van Der Wal, A C ^a   Niessen, H W M ^b   Koch, K T ^a   De Winter, R J ^a   Van Der Loos, C M ^a   Rittersma, S Z H ^a   Chamuleau, S A J ^a   Tijssen, J G P ^a   Becker, A E ^a   Piek, J J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD68 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C5B; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN;

ACUTE HEART INFARCTION; ADULT; ARTERY MEDIA; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DIRECTIONAL ATHERECTOMY; FEMALE; FROZEN SECTION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RANDOM SAMPLE; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ANGINA PECTORIS; ANGINA, UNSTABLE; ATHERECTOMY, CORONARY; C-REACTIVE PROTEIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 32544448716     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.027235     Document Type: Article

References (38)

1. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-18.
2. Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18:1386-92.
3. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992;4:361-8.
4. Pasceri V, Willerson JT, Yeh ETH. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-68.
5. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-7.
6. Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001;103:1955-60.
7. Wolbink G, Brouwer M, Buysmann S, et al. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 1996;157:473-9.
8. Campeau L. Grading of angina pectoris [letter]. Circulation 1976;54:522-3.
9. Braunwald E. Unstable angina. A classification. Circulation 1989;80:410-14.
10. Meuwissen M, Chamuleau SAJ, Siebes M, et al. Hyperemic coronary stenosis resistance better identifies functionally significant lesions than physiological indexes based on intracoronary pressure or flow velocity alone. Circulation 2000;102(suppl II):3096.
11. Trakht IN, Kovaleva KA, Janushevskaya EV, et al. Investigation of human blood plasma Apo B-containing lipoproteins by means or monoclonal antibodies against low density lipoproteins. Atherosclerosis Reviews 1988;17:51-66.
12. van der Loos CM, Das PK, Van den Oord JJ, et al. Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods 1989;117:45-52.
13. van der Loos CM, Gobel H. The animal research kit (ARK) can be used in a multistep double staining method for human tissue specimens. J Histochem Cytochem 2000;48:1431-8.
14. Lagrand WK, Niessen HWM, Wolbink G-J, et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997;95:97-103.
15. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1996;94:3090-7.
16. van der Wal AC, Becker AE, Koch KT, et al. Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques. Heart 1996;76:312-16.
17. Polkowski W, Meijer GA, Baak JP, et al. Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus. Anal Quant Cytol Histol 1997;19:246-54.
18. Meuwissen M, van der Wal AC, Koch K, et al. Complex coronary artery stenosis and unstable angina are positively associated with the extent of plaque inflammation. Am J Med 2003;114:521-7.
19. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-72.
20. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-60.
21. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
22. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
23. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
24. Munford RS. Statins and the acute-phase response. N Engl J Med 2001;344:2016-18.
25. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
26. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
27. Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001;158:1039-51.
28. Calabro P, Willerson JT, Yeh ETH. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003;108:1930-2.
29. Jabs WJ, Theissing E, Nitschke M, et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003;108:1428-31.
30. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
31. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
32. Quinn MT, Parthasarathy S, Fong LG, et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/ macrophages during atherogenesis. Proc Natl Acad Sci U S A 1987;84:2995-8.
33. Bhakdi S, Torzewski M, Klouche M, et al. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 1999;19:2348-54.
34. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999;42:23-30.
35. Burke AP, Tracy RP, Kolodgie F, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002;105:2019-23.
36. Piek JJ, van der Wal AC, Meuwissen M, et al. Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. J Am Coll Cardiol 2000;35:963-7.
37. Meuwissen M, Piek JJ, van der Wal AC, et al. Recurrent unstable angina after directional coronary atherectomy is related to the extent of initial coronary plaque inflammation. J Am Coll Cardiol 2001;37:1271-6.
38. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-65.